Stay updated with breaking news from Script United States. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- GenScript USA Inc., the world's leading life-science research tools and services provider, is collaborating with researchers at the...
GenScript USA Inc., a global leader in life science research tools and services, recently announced the launch of the GenWand™ Double-Stranded DNA (dsDNA) service for the production of CRISPR knock-in homology-directed repair (HDR) templates in T cell engineering.
The recent announcement, delivered at the American Society of Gene & Cell Therapy’s (ASGCT) 25th annual meeting, cements GenScript’s position as the leading provider of non-viral homology-directed repair (HDR) template solutions for immune-cell engineering.
Share this article Share this article PISCATAWAY, N.J., Feb. 11, 2021 /PRNewswire/ -- GenScript USA Inc., the world's leading life science research tools and services provider, announced today that it has received Emergency Use Authorization by the U.S. Food and Drug Administration's Center for Biologics Evaluation and Research (CBER) for use of the cPass™ SARS-CoV-2 Neutralization Antibody Detection Kit in convalescent plasma screening. The cPass kit is the first FDA authorized test that specifically detects COVID-19 neutralizing antibodies without the use of live virus. Neutralizing ant...